Aimovig 140 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FB9JB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,998
Award facts
- Contract value 100% obligated
- $16,997.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,997.53 to AmerisourceBergen Drug Corp for the supply of Aimovig 140 mg/ml autoinjectors on December 2, 2025, with completion expected by December 3, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The autoinjector delivery supports military healthcare requirements, as Aimovig is a monoclonal antibody treatment primarily used for migraine prevention.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role as a prime vendor within the DLA's global pharmaceutical support network, which enables efficient distribution of specialized medications and medical commodities to support Department of Defense healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FB9JB?
SPE2DR26FB9JB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FB9JB worth?
The government has obligated $16,998 on SPE2DR26FB9JB.
Is contract SPE2DR26FB9JB an order under another contract?
Yes. SPE2DR26FB9JB is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9JB competed?
The extent of competition for SPE2DR26FB9JB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award